Recent Updates
Recently added Catalysts
VIR Positive Sentiment Score: 70/100

Vir Biotechnology to Participate in the 22nd Annual Needham Virtual Healthcare Conference

Tuesday, April 11, 2023 1 min read
Key Takeaway: Vir Biotechnology, Inc. has announced that Phil Pang, M.D., Ph.D., will participate in a fireside chat during the 22nd Annual Needham Virtual Healthcare Conference. The event is scheduled for April 18, and a live webcast of the presentation will be available on Vir's website. This participation emphasizes Vir's dedication to engaging with investors and showcasing its immunology advancements. The company's current development pipeline focuses on significant infectious diseases, including COVID-19 and hepatitis viruses.

Market Sentiment Analysis

POSITIVE FACTORS

  • Phil Pang will represent Vir Biotechnology at a prestigious healthcare conference.
  • The participation highlights Vir's commitment to sharing insights with investors.
  • The event may enhance visibility and investor interest in Vir's innovative pipeline.

Full Press Release Details

SAN FRANCISCO, April 11, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Phil Pang, M.D., Ph.D., Executive Vice President, Chief Medical Officer and Interim Head of Research, is scheduled to participate in a fireside chat at the 22nd Annual Needham Virtual Healthcare Conference on Tuesday, April 18, at 12:00 p.m. PT / 3:00 p.m. ET.
A live webcast of the presentation can be accessed under Events & Presentations in the Investors section of the Vir website at www.vir.bio and will be archived there for 30 days.
About Vir Biotechnology
Vir Biotechnology is a commercial-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of product candidates targeting COVID-19, hepatitis B and D viruses, influenza A and human immunodeficiency virus. Vir routinely posts information that may be important to investors on its website.

Tags

Needham Healthcare Conference

Frequently Asked Questions

When is Vir Biotechnology's fireside chat scheduled?

The fireside chat is set for April 18 at 12:00 p.m. PT / 3:00 p.m. ET.

Who will participate in the fireside chat?

Phil Pang, M.D., Ph.D., will participate in the discussion.

How can I access the live webcast of the event?

You can access the live webcast on Vir's website under Events & Presentations.

What focus areas does Vir Biotechnology concentrate on?

Vir focuses on treating serious infectious diseases using immunologic insights.

What viruses are targeted by Vir's development pipeline?

Vir targets COVID-19, hepatitis B and D, influenza A, and HIV.

Tags: VIR Viatris Investor Conferences Healthcare Vir Biotechnology Phil Pang Needham Conference COVID-19 HIV
Last updated: Apr 11, 2023